N-cyclopentyl-2-[(2,6-dichlorophenyl)methyl-(2-phenylsulfanylacetyl)amino]-3-phenylpropanamide
C29H30Cl2N2O2S — CID 133251592
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-cyclopentyl-2-[(2,6-dichlorophenyl)methyl-(2-phenylsulfanylacetyl)amino]-3-phenylpropanamide
N-cyclopentyl-2-[(2,6-dichlorophenyl)methyl-(2-phenylsulfanylacetyl)amino]-3-phenylpropanamide (PubChem CID 133251592) has the molecular formula C29H30Cl2N2O2S and a molecular weight of 541.54 g/mol. Its IUPAC name is N-cyclopentyl-2-[(2,6-dichlorophenyl)methyl-(2-phenylsulfanylacetyl)amino]-3-phenylpropanamide.
Molecular Properties
| Compound Name | N-cyclopentyl-2-[(2,6-dichlorophenyl)methyl-(2-phenylsulfanylacetyl)amino]-3-phenylpropanamide |
|---|---|
| PubChem CID | 133251592 |
| Molecular Formula | C29H30Cl2N2O2S |
| Molecular Weight | 541.54 g/mol |
| Exact Mass | 540.14 |
| IUPAC Name | N-cyclopentyl-2-[(2,6-dichlorophenyl)methyl-(2-phenylsulfanylacetyl)amino]-3-phenylpropanamide |
| SMILES | O=C(NC1CCCC1)C(Cc1ccccc1)N(Cc1c(Cl)cccc1Cl)C(=O)CSc1ccccc1 |
| InChI | InChI=1S/C29H30Cl2N2O2S/c30-25-16-9-17-26(31)24(25)19-33(28(34)20-36-23-14-5-2-6-15-23)27(18-21-10-3-1-4-11-21)29(35)32-22-12-7-8-13-22/h1-6,9-11,14-17,22,27H,7-8,12-13,18-20H2,(H,32,35) |
| InChIKey | DVOMJEGMMPKAFK-UHFFFAOYSA-N |
| XLogP | 6.78 |
| TPSA | 49.41 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 541.54 |
| LogP ≤ 5 | 6.78 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 133251592 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.